HighTower Advisors, LLC - POSEIDA THERAPEUTICS INC ownership

POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 69 filers reported holding POSEIDA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.

Quarter-by-quarter ownership
HighTower Advisors, LLC ownership history of POSEIDA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$285,000
+35.1%
119,7410.0%0.00%
Q2 2023$211,000
-43.0%
119,7410.0%0.00%
-100.0%
Q1 2023$370,000
-39.8%
119,741
+3.2%
0.00%0.0%
Q4 2022$615,000
+50.4%
116,0410.0%0.00%0.0%
Q3 2022$409,000
+364.8%
116,041
+241.3%
0.00%
Q2 2022$88,00034,0000.00%
Other shareholders
POSEIDA THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Aisling Capital Management LP 1,043,267$9,254,0002.96%
SECTORAL ASSET MANAGEMENT INC 1,053,779$9,347,0000.80%
Pentwater Capital Management LP 4,879,490$43,281,0000.56%
Vivo Capital, LLC 926,449$8,218,0000.48%
Boxer Capital, LLC 1,251,055$11,097,0000.38%
Ikarian Capital, LLC 228,000$2,022,0000.15%
Perceptive Advisors 787,745$6,987,0000.10%
Rock Springs Capital Management LP 367,499$3,260,0000.08%
PURA VIDA INVESTMENTS, LLC 148,949$1,321,0000.07%
PIPER SANDLER & CO. 8,298$74,0000.06%
View complete list of POSEIDA THERAPEUTICS INC shareholders